[Event] 6th Annual Summit on Controlled Substances – Regulation, Litigation, and Enforcement

March 14th - 15th
Washington, DC
American Conference Institute (ACI)
Contact
March 14th - 15th, 2023
8:00 AM - 6:00 PM EDT
DC Bar Association
901 4th Street NW Suite 700
Washington, DC 20001

Or call 888-224-2480 for fastest service.

You can save extra 10% off the current rate by using code D10-999-JDS23.

Join American Conference Institute at the 6th Annual Summit on Controlled Substances – Regulation, Litigation, and Enforcement on March 14-15, 2023, in Washington. Hear from leading stakeholders, discuss your most pressing challenges, and walk away with tailored strategies for solutions as the opioid crisis enters its next stage.

CONFERENCE CO-CHAIRS

Gustave Eyler

Partner

Gibson, Dunn, & Crutcher LLP

Former Director of Consumer Protection Branch, U.S. Department of Justice

Jolie Apicella

Partner

Wiggin & Dana LLP

Former AUSA, Chief of Healthcare Fraud, Eastern District of New York

Cori Rizman

Director, Compliance – Controlled Substances Oversight Region North America

Fresenius-Kabi USA

Former Diversion Group Supervisor, DEA

Be part of the only conference that presents strategies and solutions for every link of the controlled substances supply chain. Connect with government officials and key industry stakeholders from throughout the controlled substances supply chain to examine the latest legal and regulatory developments impacting the industry. Attend and learn how to best conform business practices to meet industry and regulatory demands, bolster compliance programs, mitigate risk, and reduce liability.

GOVERNMENT KEYNOTES

Eric Triana

Deputy Assistant Administration, Diversion Control Division

Drug Enforcement Administration

Dominic Chiapperino

Director, Controlled Substance Saff

U.S. Food and Drug Administraction, Center for Drug Evaluation and Research, Office of the Center Director

Amanda Liskamm

Principal Deputy Director, Consumer Protection Branch

U.S. Department of Justice

Industry Thought Leaders will help you:

  • ASSESS the current status of the National Opioid Litigation and MDL Settlements
  • ANALYZE the therapeutic potential of marijuana and psychedelics
  • EVALUATE the role of Telemedicine in controlled substances prescribing, distribution, and abuse
  • DEVELOP a comprehensive Controlled Substances Compliance Program
  • RESPOND effectively to DEA and FDA investigations

Learn more about the full program and speaker faculty.

Save 10% off the current registration fee by using code D10-999-JDS23.

*Discount is valid for new registrations only and it’s not applicable for workshops.

PRESENTED BY:

American Conference Institute (ACI)
Contact
more
less

American Conference Institute (ACI) on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide